Related Experiment Video
Updated: Nov 22, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Function of Deptor and its roles in hematological malignancies
Mario Morales-Martinez1, Alan Lichtenstein2, Mario I Vega1,2
1Molecular Signal Pathway in Cancer Laboratory, UIMEO, Oncology Hospital, Siglo XXI National Medical Center, IMSS, México City, México.
Abstract:
Deptor is a protein that interacts with mTOR and that belongs to the mTORC1 and mTORC2 complexes. Deptor is capable of inhibiting the kinase activity of mTOR. It is well known that the mTOR pathway is involved in various signaling pathways that are involved with various biological processes such as cell growth, apoptosis, autophagy, and the ER stress response. Therefore, Deptor, being a natural inhibitor of mTOR, has become very important in its study. Because of this, it is important to research its role regarding the development and progression of human malignancies, especially in hematologic malignancies. Due to its variation in expression in cancer, it has been suggested that Deptor can act as an oncogene or tumor suppressor depending on the cellular or tissue context. This review discusses recent advances in its transcriptional and post-transcriptional regulation of Deptor. As well as the advances regarding the activities of Deptor in hematological malignancies, its possible role as a biomarker, and its possible clinical relevance in these malignancies.
Insights
Deptor protein inhibits mTOR signaling, crucial for cell growth and cancer. Its varied roles in hematologic malignancies highlight its potential as a biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
Background:
- Deptor is an endogenous inhibitor of the mTOR kinase, a key regulator of cell growth, apoptosis, autophagy, and ER stress.
- The mTOR pathway's involvement in numerous biological processes makes Deptor a significant focus for research, particularly in human malignancies.
Purpose of the Study:
- To review recent advances in the transcriptional and post-transcriptional regulation of Deptor.
- To explore Deptor's role in hematologic malignancies, its potential as a biomarker, and its clinical relevance.
Main Methods:
- Literature review of transcriptional and post-transcriptional regulation of Deptor.
- Analysis of Deptor's involvement in hematologic malignancies based on existing research.
Main Results:
- Deptor's expression varies in cancer, suggesting context-dependent oncogenic or tumor-suppressive functions.
- Recent advances in understanding Deptor's regulation and its specific activities in hematologic cancers are discussed.
Conclusions:
- Deptor's dual role and complex regulation underscore its significance in hematologic malignancies.
- Further research into Deptor may reveal its utility as a diagnostic biomarker and therapeutic target.
More Related Videos
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Abnormal Proliferation
Hematopoiesis
Lineage Commitment

